Enlivex Therapeutics (NASDAQ:ENLV) Given New $7.00 Price Target at HC Wainwright
Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) had its price objective increased by research analysts at HC Wainwright from $6.00 to $7.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Separately, D. Boral Capital reiterated a “buy” rating and set a $13.00 target price on shares […]
Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) had its price objective increased by research analysts at HC Wainwright from $6.00 to $7.00 in a report released on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Separately, D. Boral Capital reiterated a “buy” rating and set a $13.00 target price on shares […]
